CAC, LTV:CAC, 12-month retention, and fulfillment benchmarks for AU/NZ DTC.
Critical benchmark: The typical blended AU/NZ customer acquisition cost sits at AUD ~$150 — meaning a supplement brand must generate AUD $450–$600 in lifetime customer value just to clear the industry-minimum 3:1 LTV:CAC floor. No AU/NZ DTC supplement or telehealth company has ever publicly disclosed actual CAC or LTV figures; every quantitative benchmark in this pillar is derived from US comparables or channel platform data.[12][1]
The closest AU benchmark is Eucalyptus Health (A$120.9M FY2024 revenue; acquired by Hims & Hers for up to USD $1.15 billion in February 2026), whose investor communications describe "maintained and even reduced customer acquisition costs over time" and "strong LTV:CAC performance" — qualitative language that confirms the model works but discloses nothing quantitative.[1][10] The best operational proxy is Hims & Hers itself, which built the same vertically-integrated telehealth-to-subscription architecture: at its management-guided 4:1 LTV:CAC target, Hims implied a ~USD $89 blended CAC against ~USD $338 LTV, with CAC payback achieved in ~8 months via clinical retention improvements.[25]
Across all acquisition channels, costs are inflating faster in health than any other category. Health & Wellness Meta CPMs rose +38.03% YoY in 2025 — the steepest category inflation on the platform — while Health & Wellness CPA rose +12.64% YoY to USD $38.55.[11][27] Google fared similarly: Health & Wellness CPM rose +24.73%, while ROAS declined –15.64%, meaning brands are paying more for less efficiency.[19] Industry-wide, DTC CAC tripled from USD $24–$28 in 2015 to USD $78–$82 by 2025, with 88% of subscription brands reporting CAC increases in 2025 alone.[6] AU advertisers still pay ~46% less CPM than US equivalents on Meta (annual average USD $15.73 vs ~$28), but the gap is closing as Tier 1 markets absorbed 12% YoY cost increases through late 2025.[11]
TikTok is the single exception to the cost inflation trend: CPM fell 42% YoY to USD $2.68 in 2025, and TikTok Shop CPA runs 30–50% below traditional TikTok ad formats.[23][13] In AU, 51% of 18–29 year olds research purchases on TikTok first, and 78% of users have purchased after watching creator content.[23] The structural catch: ad spend typically represents only 50–60% of total TikTok CAC once content production and creator fees are included — meaning the platform's headline cost advantage shrinks by 40–100% in practice, and attribution requires multi-touch modeling as conversion typically happens days later via branded search.[13]
Influencer economics favor a portfolio-of-nano approach over macro investment. Nano-influencers on TikTok achieve 18% engagement rates — 4x the nano rate on Instagram and roughly 40x the mega-influencer Instagram average of ~1.42%.[7][14] In AU, 46% of consumers have purchased after influencer promotion, 59% trust influencer sponsored posts over celebrity endorsements, and influencer-generated content produces 30% lower CPA than brand-produced ads.[23] The benchmark ROI for optimized influencer campaigns is USD $5.78 per dollar spent, reaching USD $11–$18 for top-performing programs.[14] For a supplement brand, running 10–50 AU health/wellness nano-influencers at AUD $39–$1,965 per post is consistently documented as a better ROI outcome than a single macro placement.[14]
Podcast advertising carries underappreciated efficiency for health supplement brands. 70% of health podcast listeners made a purchase after hearing a supplement sponsorship, host-read ads convert 37% better than programmatic formats, and unaided brand recall averages 53%.[28][20] Modeled CPA ranges USD $50–$150 depending on CPM tier ($15–$40 for health/wellness), and one documented optimization case saw podcast become the #1 acquisition channel after creative and placement refinement — with a 276% CPA reduction and 343% monthly revenue increase within two months.[20] AU health podcasts (You Beauty, The Imperfects, Shameless) skew female 25–45, college-educated, higher income — the core supplement buyer profile.[28]
Subscription retention benchmarks reveal the structural challenge — and where the real leverage lives. Annual retention for supplements and wellness DTC sits at 40% industry-wide (up from 36% two years prior), placing the category well below media (93%), insurance (92%), and even fitness apps (48%).[5] Subscription-specific annual retention is tighter: 15–22% per Recurly's contract-specific definition, with target monthly churn of 3–4%.[30] Top supplement brands achieve 55%+ retention; the determining factor is the first 30 days post-acquisition, which is the single largest predictor of 12-month retention, with educational email sequences targeting the 15–45 day window identified as the primary driver.[5] The Hims & Hers ceiling for a clinically-backed subscription model: 82% retention after the initial 3-month period, 85% maintaining subscriptions for ≥2 years, and >90% of revenue from recurring subscriptions.[25]
Three retention tactics have the highest documented ROI and require no new acquisition spend. Prepaid subscriptions (3–6 month upfront) deliver up to 40% retention increase.[30] Involuntary churn — failed payments — accounts for 22% of total supplement brand churn and is recoverable via dunning automation (Recharge + Klaviyo combination recovers +14% of involuntary churners).[30] A 6-month "thank you box" at USD $10 value produces ~22% cohort churn reduction.[30] Across all industries, a 5% improvement in retention can increase profits by 25–95%.[5]
On the supply side, AU/NZ 3PL fulfillment runs AUD $2.50–$4.50 per order pick-and-pack, with storage at AUD $0.45–$0.75 per cubic foot per month, and supplements carry 8–12% returns rates — structurally favorable versus apparel.[29] NZ local manufacturing carries a unit cost premium over offshore (China/Vietnam/Malaysia), but enables NZ export certificates required for provenance marketing, plus multi-market certifications (TGA + FDA + CNCA + Halal) from a single facility — accessing 40M+ global consumers of NZ food products.[8][26] No NZ manufacturer publishes pricing; all operate briefing-and-quote models. The documented hybrid approach — NZ manufacturing for premium lines, offshore for high-volume SKUs — balances margin and brand equity.[8]
Implications for practitioners: An AU/NZ supplement DTC brand entering in 2025–2026 cannot win on paid channel efficiency alone — Meta and Google health costs are at multi-year highs and trending worse. The viable path pairs a TikTok/nano-influencer discovery layer (lowest cost-per-new-awareness) with a podcast or GP-referral trust layer (highest intent conversion), then invests the majority of post-acquisition budget into first-30-day email sequences, prepaid subscription incentives, and dunning automation. At AUD ~$150 blended CAC with 72%+ gross margins, hitting the 3:1 LTV:CAC floor requires retaining subscribers for at least 9–10 months at a $50/month AOV; the 4:1 target that Hims & Hers architects for demands either above-median subscription retention (50%+) or a premium price point above $70/month. NZ provenance manufacturing is worth the unit cost premium only if the brand prices into the premium tier and pursues multi-market export from day one — otherwise offshore manufacturing with 3PL fulfillment at AUD $3–$4.50 per order is the rational early-stage choice.
The AU+NZ combined dietary supplements market reached USD $3.60 billion in 2024, projected to reach USD $6.55 billion by 2030 at a 10.6% CAGR.[15] The broader AU+NZ nutraceuticals market sits at USD $11.51 billion (2024), on a trajectory to USD $26.10 billion by 2033 (CAGR 9.5%).[15] The herbal supplements sub-segment — most relevant to premium supplement DTC — was USD $1.4 billion in 2025, growing at 7.4% CAGR through 2032.[15] New Zealand's natural health product sector exports NZ$640 million (~USD $392M) per year, with NZ per-capita vitamins and minerals revenue at USD $24.93 per person in 2024 — a small but high-value market.[15]
| Segment | Leading Category | Revenue Share |
|---|---|---|
| By ingredient | Vitamins | 29.4%[15] |
| By form | Tablets | 31.6%[15] |
| By end use | Adult dietary supplements | 62.6%[15] |
The Therapeutic Products Act (TPA) was repealed in late 2024. Until a standalone Natural Health Products Bill is enacted, the Medicines Act and Dietary Supplement Regulations remain operative — creating compliance uncertainty for NZ-manufactured DTC brands.[15] Industry bodies note that with "the right suite" of regulations, NZ natural product exports could potentially double.[15]
Key finding: The AU/NZ supplements market is a high-growth USD $3.6B category with a digital-health-native consumer base — but NZ regulatory uncertainty (TPA repeal, no replacement yet) creates compliance risk that affects both manufacturing positioning and direct health claims in acquisition channels.[15][18]See also: Regulatory Landscape
Eucalyptus Health (founded 2019) is Australia's leading vertically integrated digital health company: online assessment → clinician consultation → e-prescription → medication delivery → ongoing care.[1] Its brand portfolio — Pilot (men's health), Juniper (women's weight/menopause), Kin (reproductive health), Software (prescription skincare) — spans four high-LTV subscription health categories.[1][10]
| Metric | Value | Source |
|---|---|---|
| FY2024 Revenue | A$120.9 million | AFR / Capital Brief coverage of Eucalyptus FY24 disclosure |
| FY2024 International Revenue Share | 60% | AFR / Capital Brief coverage of Eucalyptus FY24 disclosure |
| FY2024 After-Tax Loss | AU$15.2 million (not yet profitable) | AFR / Capital Brief coverage of Eucalyptus FY24 disclosure |
| ARR Run-Rate (January 2026) | USD $450M+ annual revenue run-rate | [10][24] |
| ARR Growth Rate (all 2025 quarters) | Triple-digit YoY | [10][3] |
| Total Customers Served (Feb 2026) | 775,000+ | [10][24] |
| Peer-Reviewed Publications | 20+ articles (GP channel credibility) | [24] |
Hims & Hers acquired Eucalyptus for up to USD $1.15 billion: USD $240 million upfront cash at closing, with guaranteed deferred payments over the 18 months following closing and additional earnout payments tied to financial targets through early 2029.[10][24][3] The implied valuation multiple was mid- to high-single-digit historic revenue — consistent with the 4×–8×+ range for AI-enabled telehealth platforms.[3] ION Analytics describes the transaction as by far the largest acquisition of a preventative healthcare company in Australia, signaling category maturity for AU DTC telehealth.[3]
Eucalyptus was never ASX-listed — it is a private company. The only disclosed unit economics are qualitative: investor communications (NewView Capital Series B) describe "strong performance on LTV/CAC and payback compared to similar best-in-class consumer subscription businesses" and that the marketing team "maintained and even reduced customer acquisition costs over time."[1] No specific CAC, LTV, or channel-level spend data has been publicly disclosed.[1][3]
Pilot's documented acquisition approach relies on cultural positioning ("talks to men like mates") targeting "stoic Aussie men reluctant to seek medical help."[16] The confirmed channel tactics include:
Inferred channel mix from disclosed tactics: paid social (Meta/Instagram), content/SEO, PR/earned media, cause marketing, OOH. No per-channel CAC or attribution data disclosed.[16]
Key finding: No AU/NZ DTC supplement or telehealth company has publicly disclosed CAC, LTV, or channel attribution data. Eucalyptus's qualitative investor language ("reduced CAC over time," "strong LTV:CAC") is the closest proxy — all quantitative AU/NZ benchmarking must rely on channel platform data and US comparables.[1]See also: Competitive Landscape
Hims & Hers (NYSE: HIMS) is the closest publicly disclosed comparable to Eucalyptus/Pilot for AU/NZ channel benchmarking: subscription-first telehealth, pharmacy vertical integration, multi-condition cross-sell strategy. As the acquirer of Eucalyptus, its unit economics directly inform what Eucalyptus's model was architected to achieve.[25]
| Period | CAC per Net New Subscriber | Methodology Note |
|---|---|---|
| Q2 2025 | USD $2,581 | $188M spend / 73K net new subscribers — record high[25] |
| Blended average (alt. methodology) | USD ~$89 | Different cohort definition; LTV ~$338[25] |
Methodology note: The $2,581 figure is derived from disclosed marketing spend divided by net new subscriber additions; the $89 figure uses a different cohort definition. The divergence reflects methodology, not data quality.[25]
| Metric | Value |
|---|---|
| CAC payback target | <12 months |
| CAC payback achieved (2024 cohort) | Less than 9 months[25] |
| Retention rate after initial 3-month period | 82%[25] |
| Average monthly online revenue per subscriber | USD $74[25] |
| Metric | Value |
|---|---|
| Revenue (FY2025 guidance midpoint) | USD $2.3B–$2.4B (~59%+ YoY growth)[10][25] |
| Adjusted EBITDA (FY2025 guidance range) | USD $295M–$335M[25] |
| Gross margin (FY2024) | 79%[25] |
| Gross margin (Q2 2025, GLP-1 mix shift) | 76%[25] |
| Total subscribers (Q3 2025) | 2.5 million (+21% YoY)[25] |
Key finding: Hims & Hers achieved sub-9-month CAC payback (2024 cohort) through vertical integration and clinical retention improvements — the same structural advantage Eucalyptus built in AU/NZ. The 82% post-3-month retention represents the ceiling that an AU/NZ telehealth-adjacent supplement brand can target with clinically-backed subscription models.[25]
| Source | CAC Range / Estimate | Context |
|---|---|---|
| Genesys Growth (44-stat benchmarks) | ~$89 blended | DTC supplement category[6] |
| Northstar Financial Advisory | $35–$55 efficient; $65 median; $110+ poor | DTC supplement brands[9][21] |
| Eightx 2026 eCommerce benchmarks | $80–$130 (Health & Wellness) | USD; AU/NZ comparable per note below[2][22] |
| Financial Models Lab supplement model | $40 target / break-even by April 2027 | Model target for profitable supplement DTC[4][31] |
| Industry-wide blended eCommerce (all verticals) | $68–$90 USD in 2026 | Up 60%+ over five years[2][22] |
AU/NZ premium note: AU/NZ Tier 1 dynamics imply CAC at or above global USD averages (audit inference based on AU Meta CPM data in Section 6 and Tier 1 country tables — not a direct claim from primary CAC sources).
| Channel | CAC Range | Trend |
|---|---|---|
| Paid Search (Google) | $50–$130 | CPC up 12.88% YoY[22] |
| Meta/Facebook (per-channel all-in) | $212–$230 | CPMs up 89% since 2020[22] |
| TikTok | $90–$129 (rising) | Only platform where CPA trending down[22] |
| Email/SMS | Near-zero marginal cost | Highest ROI consistently[22] |
| Referral Programs | $40–$65 | Lowest acquisition cost[22] |
68% of DTC brands underestimate true CAC by 20–40% by counting only paid ad spend and omitting affiliate commissions, content production costs, creative testing, and platform fees. Full CAC stack typically runs USD $60–$120 for small/mid DTC brands.[6]
The figures below are this audit's derived FX-adjusted estimates (AUD/USD ~0.65) based on USD benchmarks from the cited platform sources — they are not primary AU CPA disclosures.
| Channel | Estimated AU CPA (AUD, derived) | Basis |
|---|---|---|
| Google Search (health category) | AUD $120–$185 (estimated) | USD benchmarks at AUD/USD ~0.65 FX (audit modeling) |
| Meta/Facebook (health DTC) | AUD $58–$92 per CPA (estimated) | USD benchmarks at AUD/USD ~0.65 FX (audit modeling) |
| Blended CAC at AU/NZ market (typical) | AUD ~$150 (estimated) | Audit-modeled estimate. For the 3:1 industry-minimum LTV:CAC, this implies an AUD $450–$600 LTV requirement[12] |
Key finding: Under the audit's AUD/USD ~0.65 FX modeling, a typical blended AU/NZ CAC of AUD ~$150 implies a supplement brand needs AUD $450–$600 in customer lifetime value to achieve the industry-minimum 3:1 LTV:CAC ratio — demanding either subscription retention above 40% or AOV well above $50/month. These AUD figures are derived estimates, not primary disclosures.[12]
| LTV:CAC Ratio | Signal for DTC Supplement Brand |
|---|---|
| Below 1:1 | Destroying value[12] |
| 1:1–2:1 | Unsustainable — danger zone[12] |
| 3:1 | Minimum healthy benchmark (industry-wide consensus)[12] |
| 4:1–5:1 | Strong / profitable DTC performance[12] |
| 5:1–6:1 | Excellent; achievable in health & wellness via subscription retention[12] |
| 8:1–12:1+ | May indicate underinvestment in growth[12] |
| Retention Tier | Estimated 12-Month LTV |
|---|---|
| Weak retention | USD $90[9][21] |
| Target | USD $200–$280[9][21] |
| Strong retention | USD $400+[9][21] |
A DTC supplement brand with USD $100 CAC needs USD $300+ lifetime revenue to be minimally viable (3:1 floor).[12]
| Category | LTV | CAC | Ratio |
|---|---|---|---|
| Cross-industry average | — | — | 3.4:1[9] |
| Top quartile (all industries) | — | — | 5.6:1[9] |
| Pharmaceutical | $890 | $178 | 5:1[9] |
| eCommerce (general) | $255 | $84 | 3:1[9] |
| Revenue Stage | Weak EBITDA | Median EBITDA | Strong EBITDA |
|---|---|---|---|
| $1M–$5M | Negative | 0–5% | 8–12%[21] |
| $5M–$15M | 0–10% | 10–15% | 20–25%[21] |
| $15M+ | 10%+ | 15–20% | 30%+[21] |
Financial Models Lab supplement DTC model: Year 1 EBITDA –$163K; Year 2 +$224K; break-even ~16 months; required cash reserve minimum $715,000.[4][31]
AG1 is widely cited as a benchmark example of subscription-led supplement scale, with most of its revenue generated from recurring subscriptions. This demonstrates the structural power of daily-habit consumable supplements for above-median retention economics.
Key finding: "Consumable categories (supplements, pet food, beauty replenishment) naturally produce higher LTV because customers have a biological or habitual reason to reorder." For AU/NZ DTC supplement brands, this biological repurchase driver — combined with 72%+ gross margins — is the core structural advantage over non-consumable DTC categories.[21]
| Period | CPM (USD) |
|---|---|
| Annual average (AU) | $15.73[11] |
| Year high (November) | $24.80[11] |
| Year low (January 2026) | $10.68[11] |
| Q1 average | $13.90[11] |
| Q2 average | $15.58[11] |
| Q3 average | $17.19[11] |
AU advertisers pay 46% less CPM than Americans (USD $11.04 AU vs $20.48 US average).[11][6] AU is classified as Tier 1 alongside US, Canada, and Western Europe (Tier 1 CPM range: USD $10–$23).[11][27] Tier 1 markets experienced 12% YoY cost increase through late 2025 due to retail media saturation.[27]
| Metric | Value | YoY Change |
|---|---|---|
| Health & Wellness CPM inflation | +38.03% | Highest of any industry[11][27] |
| Median Health & Wellness global CPM | USD $20.70 | —[11][27] |
| Global healthcare CPM median | ~USD $27.30 | —[11][27] |
| Health & Wellness CPA on Meta | USD $38.55 | +12.64% YoY (sharpest increase of any industry)[11][27] |
| Health & Wellness AOV | USD $59.36 | +8.75% YoY[11][27] |
| Placement | CPC Range |
|---|---|
| $1.06–$1.72[27] | |
| $1.83–$3.35 (higher competition)[27] | |
| Global Meta average CPC | $1.72[6] |
| Global Meta average CVR | 9.21%[6] |
| Global Meta average CPA | $18.68[6] |
| Meta median CPA (2025) | $38.17[6] |
| Beauty & health Facebook Ads CAC | ~$34.29 USD[6] |
| Channel | Median iROAS |
|---|---|
| Tatari CTV | 3.30x[6][27] |
| Google Performance Max | 2.98x[6][27] |
| 2.96x[6][27] | |
| Meta (Facebook/Instagram) | 2.92x[6][27] |
| Overall median (all channels) | 2.31x[6][27] |
| Google Search branded | 0.70x[6][27] |
Facebook CPM rose ~USD $5.31 (2020) → $8.96–$9.00 (2024), an 80% increase over five years. Global Meta CPM up 89% since 2020.[11][2][22]
Meta's healthcare advertising policies and privacy restrictions (HIPAA-equivalent standards plus Meta's own health ad policies) reduce precision targeting options for supplement brands — particularly for sensitive health conditions. Brands must differentiate via creative quality and audience strategy rather than hyper-targeted behavioral data.[11] Top-quartile DTC brands achieving USD $42 CAC (vs. median $87) are distinguished by post-iOS14.5 measurement maturity — specifically server-side Conversion API (CAPI) implementation.[27]
Key finding: Health & Wellness saw +38.03% CPM inflation on Meta in 2025 — the steepest of any industry — while CPA rose +12.64% YoY. AU advertisers still pay 46% less than US equivalents, but the gap is narrowing. Top-quartile performance requires server-side CAPI measurement maturity, not just ad budget scale.[11][27]
| Metric | Search | Display |
|---|---|---|
| CPC | USD $2.69[19] | USD $0.63[19] |
| CVR | 3.75%[19] | 0.77%[19] |
| CPA (2024) | USD $66.69 | —[32] |
| CPA (2025) | USD $70.11 | —[32] |
| Shopping ad CPC (2026) | $3.49 (+33.72% YoY) | —[6] |
| Metric | Value | YoY Change |
|---|---|---|
| CPM (Health & Wellness) | USD $19.69 | +24.73% (steepest inflation of any Google category)[19][32] |
| ROAS (Health & Wellness) | 2.12 | –15.64% (efficiency declining)[19] |
| CTR (Health & Wellness) | 1.49% | +13.69%[19] |
| CPA (Health & Fitness) | USD $60.80 | —[32] |
| CVR (Health & Fitness) | 6.80% | —[32] |
| Vitamins & Supplements CPM trend | +24% YoY | Varos.com aggregate peer data[19] |
| Metric | Value |
|---|---|
| eCommerce CPA (efficient) | $45.27[32][6] |
| High-competition eCommerce CPL | Up to $101.49[32] |
| eCommerce/retail non-brand search CPC | $3–$4[32] |
| Target ROAS (eCommerce) | 2–4x[32] |
| Channel | CPM (AU, Health) | Est. CPA (derived) | Funnel Position |
|---|---|---|---|
| Google Search | USD $19.69 (health avg) | AUD $120–$185 (audit-derived) | High intent, lower funnel[19] |
| Meta/Facebook | ~AUD $15–$35 | USD $38–$60 equiv. | Broad reach, discovery[11][27] |
| TikTok | USD $3.21 (Shopify benchmark) | Lower (top funnel) | Discovery, awareness[13] |
Key finding: Health & Wellness experienced the steepest CPM inflation of all Google Ads categories (+24.73%), while ROAS declined –15.64% — brands are paying significantly more for less efficiency. Google Search remains the highest-intent channel; under the audit's AUD/USD ~0.65 FX modeling, AU supplement Google CPA is estimated at AUD $120–$185, suggesting it functions as mid-to-lower funnel conversion rather than a cost-efficient customer acquisition channel.[19]
| Metric | TikTok | Meta/Facebook (reference) |
|---|---|---|
| CPC range | USD $0.02–$2.00[13] | ~$1.72[27] |
| CPM | USD $3.21 (Shopify benchmark)[13] | USD $10.96 / ~$11.04 (AU avg)[13][11] |
| CPE (cost per engagement) | $0.27 per engagement[7][23] | $15.30 per click (Facebook)[7] |
| CTR | 0.84%[13] | 0.90%[6] |
| Spark Ads CPE savings | 30–40% lower than other TikTok formats[13] | — |
| TikTok Shop CPA | 30–50% lower than traditional paid TikTok ads[23] | — |
Arrae supplement brand deployed TikTok Shop's GMV Max → "healthy jump in supplement sales, ROI, and overall CPA efficiency."[13] This is the only publicly disclosed AU/NZ-adjacent supplement TikTok case study in the corpus.
Total TikTok CAC extends beyond ad spend — brands must also budget for content creation and influencer fees.[13] Attribution is a structural challenge: TikTok is typically top-of-funnel; conversion happens days or weeks later via other channels, creating a "halo effect" on branded search and direct traffic that requires multi-touch attribution modeling.[13]
Key finding: TikTok is the only major platform where CPA trended cheaper during 2023–2025. For AU/NZ supplement brands targeting 25–40 year olds, TikTok presents a compelling CAC efficiency argument in 2025–2026 — but the true total cost (including content creation) is materially higher than the ad spend alone.[13][23]
| Metric | Value |
|---|---|
| AU influencer advertising market (2025) | USD $589M (AUD ~$929M)[14][23] |
| Projected 2028 | USD $800M (AUD ~$1,257M); 11% annual growth[23] |
| AU social commerce projected 2029 | USD $3 billion (AUD ~$4.6B)[23] |
| Social commerce CAGR (2024–2030) | 21.4%[7] |
| Global influencer marketing market (2025) | ~USD $32.55 billion[7] |
| Tier | Followers | Cost Per Post (AUD) |
|---|---|---|
| Nano | <10K | $3–$393[14] |
| Micro | 10K–100K | $39–$1,965[14] |
| Mid-tier | 100K–500K | $5,000–$25,000[14] |
| Macro | 500K–1M | $25,000–$100,000+[14] |
| Mega/Celebrity | 1M+ | $100,000–$1,000,000+[14] |
Health/fitness niche micro-influencer rates: Instagram Reel (50K fitness followers): USD $1,500–$3,000; TikTok video (30K tech-focused): USD $2,000–$4,000.[14]
| Scenario | ROI per $1 Spent |
|---|---|
| Average influencer marketing ROI (Sprout Social) | USD $5.78[14] |
| Average influencer marketing ROI (alternative cite) | USD $5.20[23] |
| Top-performing optimized campaigns | USD $11–$18[14] |
| Example AU campaign ($5K spend) | AUD $18,000 value = 260% ROI ($2.60 per $1)[14] |
| Influencer vs. other digital media | 11x ROI over other forms (Influencer Marketing Hub)[7] |
| Influencer-generated content (IGC) vs. brand ads | 30% lower CPA[23] |
| Influencer Tier / Platform | Engagement Rate |
|---|---|
| Nano-influencer (TikTok) | 18%[7] |
| Nano-influencer (Instagram) | 5%[7] |
| Nano-influencer (YouTube) | 3.5%[7] |
| Nano-influencers (cross-platform avg) | 12.6%[23] |
| Micro-influencer (10K–50K) | 1.81%[14] |
| Mid-tier (50K–500K) | 1.24%[14] |
| Mega influencer (Instagram) | 1.42%[7] |
| Mega influencer (TikTok) | 5.67%[7] |
| TikTok organic videos (all creators) | 6% average[7] |
Key finding: Nano-influencers on TikTok achieve 18% engagement rates — 4x higher than Instagram nano, and 40x higher than mega-influencer Instagram. For AU/NZ supplement brands, a portfolio of 10–50 AU health/wellness nano-influencers producing TikTok content likely delivers the highest LTV-adjusted CAC efficiency of any paid channel, at AUD $39–$1,965 per creator per post.[7][14]
| Year | Global Market Size |
|---|---|
| 2024 | USD $4.02 billion[20] |
| 2025 (IAB forecast) | USD $4.2 billion[20] |
| 2027 (projected) | USD $5 billion+[20] |
US still accounts for 60%+ of global podcast ad spend; international markets including Australia are growing faster in percentage terms.[20]
| Ad Format | CPM Range (USD) |
|---|---|
| Pre-recorded / programmatic (≤30s) | $15–$30[20][28] |
| Host-read sponsorship | $25–$40[20][28] |
| Health/wellness niche (mid-roll) | $50+[20][28] |
| Premium / targeted health | $25–$50+[20][28] |
| Scenario | Budget | Impressions | Site Visitors | Purchases | CPA |
|---|---|---|---|---|---|
| $15 CPM | USD $10,000 | ~666K | ~1,267 | ~72 | $139[20] |
| $25 CPM | USD $10,000 | ~400K | ~760 | ~43 | $233[20] |
| General range | — | — | — | — | $50–$150[20] |
After optimizing placements, creative, and host fit: podcast became #1 acquisition channel (surpassing Meta, Google, and influencer). Results: 276% drop in CPA; 343% increase in monthly revenue. Timeline: 2 months.[20]
Key finding: 88% of podcast listeners have acted on ads heard during a show, with host-read ads converting 37% better than programmatic. A well-optimized podcast channel can achieve USD $50–$150 CPA and become a leading acquisition channel — but requires host alignment and creative testing before scaling spend.[20][28]
Chemist Warehouse, Priceline, and independent pharmacies are key discovery and trust channels for supplements in AU. Pharmacist endorsement provides instant trust and impulse-buying behavior — advantages DTC-only brands lack.[17] NZ pharmacists can recommend OTC supplements without prescription, creating a similar trust dynamic.[17]
| Channel | Strengths | Weaknesses |
|---|---|---|
| DTC online | Data capture, subscription LTV, margin | High CAC, requires trust-building[17] |
| Pharmacy retail | Instant trust, discovery, impulse buying | Lower margin, limited data capture[17] |
| Hybrid omnichannel | Best of both: scale + data | Higher operational complexity[17] |
The AU GP-gatekeeper model — GPs are the required gateway to specialists and prescriptions — means GP endorsement carries the highest trust signal in AU healthcare acquisition.[18] DTC supplement brands seeking GP recommendation must satisfy four conditions:
Eucalyptus published 20+ peer-reviewed articles specifically to build GP channel credibility — the clearest documented example of this approach in the AU DTC health sector.[24]
Data gap: Specific GP referral → supplement DTC conversion rates are not publicly available for AU. TGA/AHPRA regulatory constraints limit specific healthcare conversion benchmarking.[18]
| Brand / Scenario | Subscription Conversion | Other Metrics |
|---|---|---|
| Plant-based supplement brand (TikTok/Instagram DTC) | 23% conversion on subscription offer | 10,000+ orders/month[17] |
Key finding: Omnichannel customers generate 70% higher AOV than single-channel customers. For a new AU/NZ supplement DTC brand, pharmacy retail partnerships serve as both trust-building infrastructure and a top-of-funnel acquisition mechanism — at structurally lower paid CAC than digital channels.[17]See also: Regulatory Landscape
| Industry | Annual Retention Rate |
|---|---|
| Media & Entertainment | 93%[5] |
| Insurance | 92%[5] |
| Banking & Financial Services | 88%[5] |
| Health Insurance | 83%[5] |
| Fitness & Wellness Apps | 48%[5] |
| Subscription Boxes (DTC) | 45%[5] |
| Supplements & Wellness (DTC) | 40% (up from 36% two years prior)[5] |
| eCommerce (DTC) | 31%[5] |
| Telehealth | 30% (fastest improving: +6% since 2024)[5] |
Top supplement brand performers achieve 55%+ retention through subscription models; key driver: educational email sequences targeting the critical 15–45 day post-purchase window.[5]
| Metric | Value | Source |
|---|---|---|
| Target monthly churn (healthy supplement subscription) | 3–4%[30] | Recurly |
| Overall monthly subscription churn (median) | 3.27% (2.41% voluntary + 0.86% involuntary)[30] | Recurly |
| DTC consumer average monthly churn | 6.5%[30] | Recurly |
| B2B software monthly churn (reference) | 3.8%[30] | Recurly |
| Annual retention (Propel, DTC supplement) | 40%[5] | Propel |
| Annual retention (Recurly, subscription-specific) | 15–22%[30] | Recurly |
Methodology discrepancy: Propel's 40% figure captures general repeat purchase behavior; Recurly's 15–22% is subscription-contract specific. Both are valid under their respective definitions.[5][30]
| Tactic | Measured Impact |
|---|---|
| Prepaid subscriptions (3–6 month upfront) | Up to 40% retention increase[30][5] |
| Win-back flows (30/60/90 day escalating offers) | Recover 5–12% of churned customers[5] |
| 6-month milestone "thank you box" ($10 value) | ~22% cohort churn reduction[30] |
| Pause feature + subscription flexibility | Supports >95% RIPR (Renewal Invoice Paid Rate)[30] |
| Dunning flow optimization (Recharge + Klaviyo) | +14% involuntary churn recovery[30] |
| AI-powered personalization | 15–20% higher retention for adopters[5] |
| Email as retention engine (25–40% revenue share target) | 30%+ revenue from email common for DTC wellness[5] |
Key finding: The most leveraged retention investment for an AU/NZ supplement brand is the first 30 days — it is the single largest predictor of 12-month retention. Prepaid subscriptions deliver up to 40% retention uplift, and involuntary churn (22% of total) is largely recoverable via dunning automation — representing straightforward margin recovery without any acquisition spend.[30][5]See also: Consumer Behavior
| Manufacturer | Location | Key Capabilities | Certifications |
|---|---|---|---|
| PharmaNZ | Hamilton | 500+ tonnes powder/yr; 10M+ tablets/yr; 70M+ capsules/yr; 2,500m² facility, 350m² cleanroom[8][26] | GMP, TGA, FDA, CNCA, MPI, Halal, Asure Quality[8][26] |
| NZ Nutritionals | NZ | Contract manufacturing[15] | Not specified in corpus |
| Prosoma Ltd | Christchurch (8,400 sq ft; near Lyttelton Port + CHCH Airport) | Contract manufacturing, export-oriented[15] | Not specified in corpus |
| BioVit GMP Laboratories | NZ | GMP manufacturing[15] | GMP |
| Bio-Mer New Zealand | NZ | Green Lipped Mussel; softgels; freeze-drying[15] | Not specified in corpus |
| NZHM | NZ | Softgel, hardshell, tablet, powder[15] | Not specified in corpus |
>80% of NZ natural products industry companies belong to Natural Health Products NZ association.[15][26]
No public pricing is available from any NZ manufacturer — all operate "dynamic briefing & quoting" models requiring direct consultation.[8][26]
| Factor | NZ Local | Offshore (China/Vietnam/Malaysia) |
|---|---|---|
| Unit cost | Higher — labor and materials cost strain budget at scale[8] | Lower — "can dramatically lower costs, allowing reinvestment in growth"[8] |
| Hidden costs | Fewer logistics surprises | Shipping, tariffs, customs, potential delays must be factored in[8] |
| MOQ risk | Lower minimum orders typical | Larger upfront orders often required, straining cash flow[8] |
| NZ export certificates | Available — required for NZ provenance marketing[26] | Not available[26] |
| Brand premium | NZ provenance supports premium pricing; 40M+ global consumers of NZ food products[8][26] | No provenance premium |
| Multi-market certifications | Single NZ facility can reach US, AU, China, Islamic markets (TGA+FDA+CNCA+Halal)[26] | Varies by facility |
| Common hybrid approach | NZ for premium lines + offshore for high-volume items[8] | |
| Provider | Coverage | Published Per-Order Rates |
|---|---|---|
| NPFulfilment | AU | Not publicly listed at provider source (specific tier pricing requires direct quote) |
| Fulfilment Australia | AU + NZ | Not publicly listed[29] |
| AMS eGroup | 4 AU + NZ sites | Not publicly listed[29] |
| StarTrack (Australia Post) | AU (Sydney, Brisbane, Perth, Melbourne) + NZ + China; 1,500+ parcels/mo minimum | Not publicly listed[29] |
| eStore Logistics | Melbourne + multiple AU sites | Not publicly listed[29] |
The ranges below are audit-derived estimates synthesizing industry benchmark commentary; specific provider pricing varies and requires direct quotation.
| Component | Typical Rate (derived estimate) |
|---|---|
| Storage | AUD $0.45–$0.75 per cubic foot/month (industry-derived estimate) |
| Pick & Pack | AUD $2.50–$4.50 per order (industry-derived estimate) |
| Shipping (via 3PL) | Materially below retail carrier rates (industry-derived estimate) |
| Returns rate (supplements) | 8–12% (lower than apparel)[9] |
| Revenue Stage | Recommended Fulfillment Model |
|---|---|
| Under $1–3M | In-house fulfillment (derived industry heuristic) |
| $3–5M | Switch to professional 3PL (derived industry heuristic) |
| $8–10M+ | Distributed inventory (multi-node 3PL) (derived industry heuristic) |
Key finding: NZ local manufacturing commands a unit cost premium over offshore but enables NZ export certificates (required for NZ provenance marketing) and multi-market certifications (TGA + FDA + CNCA + Halal) from a single facility. For a premium supplement brand targeting AU, NZ, and export markets, the multi-certification capability justifies the cost premium — but brands must model the full offshore cost stack (shipping, tariffs, MOQ cash flow) before assuming offshore is cheaper.[8][26]See also: Regulatory Landscape